Background: TKIs are a long-term treatment for GIST, and may have an impact on caregivers. Material and Methods: For this cross-sectional study, patients and caregivers were both included when patients had been treated with TKIs for at least six months. Caregivers completed questionnaires including demographics, distress (Hospital Anxiety and Depression scale), burden (Self-Perceived Pressure from Informal Care) general health (RAND-36), comorbidity (Self-administered Comorbidity Questionnaire), social support (Social Support List -Discrepancies) and marital satisfaction (Maudsley Marital Questionnaire). Patients completed similar questionnaires, without 'burden'. We conducted analyses to explore differences between caregivers with low/moderate versus high levels of burden and low versus high levels of distress.
Introduction
Gastro-intestinal stromal tumours (GIST) belong to the rare and heterogeneous group of soft tissue sarcomas. Curative treatment consists of radical surgery, in high risk tumours combined with (neo) adjuvant imatinib [1] . Currently, the duration of adjuvant therapy is three years [2] . Until 2000, the treatment of GIST was limited, as GIST are resistant to chemo-and radiotherapy. In 2000, imatinib, a tyrosine kinase inhibitor (TKI), was introduced as the first targeted treatment for metastatic GIST. This significantly improved median overall survival from <1 year to >5 years nowadays, causing a change in life perspective for these patients [2] . Imatinib in GIST has been a successful, often prolonged, targeted treatment for GIST, both in the adjuvant and metastatic setting. More attention has recently been given to the chronicity of the disease, including the need for treatment with other TKIs when resistance to imatinib develops. This had led to the socalled Sword of Damocles, fear of recurrence or progression [3] . The approach to GIST patients and their caregivers and their needs had therefore evolved [4] . Chronic oral treatment may be accompanied by side-effects, such as, fatigue, diarrhea, nausea, periorbital oedema, muscle cramps and skin rash [5] . These adverse events, frequent radiological evaluations and related uncertainties may have an impact on patients' personal lives. We previously demonstrated that around one third of GIST patients on TKIs experience high levels of fear of cancer recurrence or progression. They also experience high levels of distress, functional impairment (emotional, social, cognitive) and have difficulties making plans for the future [3] . In a study of prostate cancer patients, treated with curative intent, we found that fear of cancer recurrence did not only adversely affect patients, but also their caregivers [6] . Little is known about how GIST and its (chronic) treatment may impact informal caregivers, while chronic fatigue, nausea and diarrhoea may conceivably impact the partner or the family. Studies have shown that cancer not only affects the individual patient and caregiver separately, but also their intertwined life as a couple [7, 8] .
Patients' longer-term mechanisms for coping with cancer and its treatment are influenced by difficulties experienced by their caregivers. Caregivers may even perceive levels of burden, distress, anxiety and decreased social support that are greater than the patient during the cancer treatment trajectory [8] . Burden is defined by Zarit et al., and mentioned in the review of Adelman et al., as 'the extent to which caregivers perceive that caregiving has had an adverse effect on their emotional, social, financial, physical and spiritual functioning' [9, 10] . This definition shows that burden is a multidimensional experience. Known risk factors for higher levels of perceived burden are diverse, but most well recognised are demographic factors, such as being female and living with the recipient of care, psychosocial factors (especially depression), fewer coping strategies and social isolation [10] . Furthermore, patient distress, spending more hours caring for the patient, financial stress, a lack of choice in becoming a caregiver and discontinuation of their own employment are risk factors [10] . High levels of burden may negatively interfere with the caregivers' general health, both physical and mental [11, 12] . Distress, defined by the National Cancer Institute as 'emotional, social, spiritual of physical pain or suffering that may cause a person to feel sad, afraid, depressed, anxious or lonely', is an important psychological morbidity, which often coincides with burden [10, 13] . Risk factors for distress are wide ranging, however worry about treatmentefficacy, managing side-effects, social isolation, lack of preparation in caring for a significant other and complexity of care are identified as more specific for caregivers of patients on active treatment for cancer [13] .
With this cross-sectional study, we aim to explore the well-being of caregivers of patients with chronic TKI treatment, by measuring burden, distress, general health, discrepancies in social support and marital satisfaction. Furthermore, we will explore whether there are the differences in caregivers experiencing high levels of burden and distress versus caregivers with low/moderate levels of burden and low levels of distress. To the best of our knowledge, this is the first study exploring well-being of caregivers of patients with GIST treated with TKIs, and is also one of the few studies exploring caregivers' well-being during long-term oral anticancer treatment.
Material and methods

Setting and participants
The cross-sectional study was conducted between June 2013 and May 2014 in the Departments of Medical Oncology at three hospitals in different regions of the Netherlands; two university medical centres and one regional hospital. Inclusion criteria for patients were: age older than 18 years, able to communicate in Dutch language, TKI treatment for at least six months in either the adjuvant or palliative setting, having an informal caregiver. Exclusion criteria for the patients were: prognosis of less than 12 weeks, able to communicate in Dutch language, no informal caregiver. A caregiver was defined as a person who cared for a patient during their chronic treatment with a TKI for GIST. This included a spouse, sibling, friend or other relative. Inclusion criteria for caregivers were: age older than 18 years. Exclusion criteria for caregivers were: not able to communicate in Dutch language. When either the patient or the caregiver met the one of the exclusion criteria, both were excluded.
Procedure
The study was approved by the local medical ethical committee (Radboud University Medical Centre 2013/278). All patients in the database of the Departments of Medical Oncology of the attending hospitals were systematically assessed for their eligibility by their attending physician. The attending physician approached the patient and their caregiver during an outpatient follow-up visit or by telephone. When the patient and the informal caregiver gave their verbal informed consent, they were included. They were both asked to a single complete self-report questionnaires, independently of each other. Completing the paper and pencil questionnaire took between 45 and 60 min. Data were analysed anonymously.
Questionnaires
Demographics
Demographic characteristics were obtained with a questionnaire, including gender, age, nationality, education, employment and relationship with each other (spouse, sibling, offspring, friend). We inquired whether the patient experienced side-effects of TKI treatment (answer possibilities: 'no, I do not experience side-effects', 'yes, I do experience sideeffect, but they are not bothersome', 'yes, I do experience side-effects and they are bothersome', 'yes, I do experience side-effects and they are extremely bothersome') and whether the patient experienced difficulties enduring longterm TKI treatment (answer possibilities: 'no', 'yes, a little bit', 'yes', 'yes, it is very difficult'). The caregiver answered questions regarding caregiving-related topics, including patients' independence, hours of caring, caring for more people than the patient, change in own health as a consequence of giving care, and neglecting own health as a consequence of being a caregiver. Duration and setting ((neo-)adjuvant or palliative) of treatment was reported by the attending physician.
Questionnaires assessing general health
The RAND-36 Health Survey is a validated, 36-item questionnaire assessing functional status, well-being and general health on eight subscales: (1) physical functioning (i.e., activities of daily living; 10 items), (2) social functioning (i.e., limitations in normal social functioning due to physical and emotional functioning), (3) role-physical (i.e., limitations in work and activity of daily living due to physical problems), (4) role-emotional (i.e., limitations in work and activity of daily living due to emotional problems), (5) mental health (i.e., regarding feelings of sadness and anxiety), (6) pain (i.e., experience of pain and limitations of activities of daily living as a consequence of pain), (7) vitality (i.e., feelings of energy and tiredness) and (8) general health (i.e., subjective evaluation of personal general health). Scores on each subscale are transformed into a range from 0 to 100. Higher scores indicate higher levels of functioning, well-being and general health. The Dutch version of the questionnaire has been validated and showed sufficient to good internal consistency (Cronbach's a 0.71-0.92) [14] .
The Self-administered Comorbidity Questionnaire is a questionnaire, assessing whether comorbidity is present, and if so, is treated and/or leads to impairments in daily functioning. The questionnaire consists of 14-items with defined medical conditions and three blank spaces to complete when a medical condition is present, but not defined in the 14-items [15] .
Questionnaires assessing mental health and social support
The Hospital Anxiety and Depression Scale (HADS) is a validated, 14-item self-assessment questionnaire to assess psychological distress [16, 17] . Total scores range between 0 and 42. Each item is rated on a scale from 0 (not at all) to 3 (very much). Higher scores indicate higher levels of distress. To identify high levels of distress on an individual basis, for patients we used the validated cutoff score for cancer patients of 11 or higher [18] . For caregivers, a cut-off score of 12 was used. This cut-off score is validated in several Dutch populations and used in other clinical studies in with cancer caregivers in the Netherlands [16, 19] .
The Social Support List -Discrepancies (SSL-D) contains 34-items to assess discrepancies between an individual's' need for social support and their perceived social support. The questionnaire assesses six types of social support, namely emotional interactions, problem-focused emotional support, esteem support, instrumental interactions, social companionship and informational support. The main question is 'Does it ever occur that people … ', which is followed by a statement, for example 'offer you mental support' or 'offer you good advice' or 'offer you constructive feedback'. The answer possibilities are (1) 'I miss this, I would like to receive this more often', (2) I do not miss this, but it would be fortunate to receive this more often, (3) The support meets my needs exactly, (4) This happens too often, it would be fortunate when it happens less. The score on every item is transformed to scores ranging from 34 to 136, with higher scores indicating more unmet need for social support [20, 21] .
Marital satisfaction was measured with the 'marital satisfaction' subscale of the Maudsley Marital Questionnaire (MMQ), a validated questionnaire to assess marital satisfaction. This is a 10-item questionnaire, answered on a 9-point scale (0-8), ranging from 0 to 80. Higher scores indicate decreased marital satisfaction [22] . We instructed participants of this study only to complete this questionnaire if they were a couple.
Questionnaire assessing giving care to a significant other
The Self-Perceived Pressure from Informal Care (SPPIC) is a Dutch, validated questionnaire to assess caregivers' selfperceived stress as a reaction to providing informal care. In the Netherlands, the questionnaire is often used among cancer caregivers to measure their perceived burden during patients' treatment. The questionnaire assesses how perceived pressure as a consequence of giving care to a significant other interferes with caregivers' personal interests, where 'personal interest' is defined as the possibility to have own thoughts, activities and/or other roles they want to fulfil in life. Examples of questions are 'As a consequence of the situation of my significant other, less time is available managing my personal life' or 'Combining the responsibility for my significant other and my family and work is challenging'. It consists of a nine-item, five-point Rasch scale. According to the questionnaire manual, the scores are dichotomized to 0 ('no!' and 'no') and 1 ('yes!', 'yes' and 'more or less'). The total scores range from 0 to 9, with higher scores indicating high levels of burden [23] . Total scores on the scale were defined as low (0-3), moderate (4-6) and high levels of burden. (7) (8) (9) This was in accordance with a study performed among caregivers of patients with oesophageal cancer [24] .
Statistical analyses
Analyses were performed using SPSS software version 20 (SPSS Inc. Chicago, IL, USA). For analysis, incomplete dyads were excluded. Descriptive statistics were used for sample characteristics. To explore the association between patients' distress and caregivers' burden and distress, Pearsons correlations were performed. For the analysis of low/moderate versus high levels of burden and low versus high levels of distress, we performed independent-samples T-test for continuous variables when equal distribution of the number of participants between group was expected. The Mann-Whitney U test was performed when normal distribution was not met between groups. For categorical variables, Chi square tests were performed and Fishers exact test was conducted when the condition of a maximum of 20% with 5 expected counts was not met. We explored whether there was a difference between low/moderate (score 0-6) versus high levels (7-9) of burden for the following variables: age, gender, relation to patient (spouse versus non-spouse), employment (yes/no), independence patient (yes/no), caring for more people than the patient with GIST (yes/no), hours of caring (<8 h/>8 h), duration of TKI use (months), setting of TKI use (adjuvant versus palliative), side effects of TKI use (yes/no), caregivers' comoribidity (yes/no), distress (HADS), discrepancies in social support (SSL-D), general health (RAND-36) and marital satisfaction (MMQ). We applied all the same variables to explore differences between high and low levels of distress, where distress (HADS) was replaced for burden (SPPIC). For all analysis, a p-value of <.05 was considered as a statistically significant difference.
Results
Caregivers' and patients' characteristics
Seventy-one couples were eligible, of whom 61 (84%) couples participated by returning the completed questionnaires. Reasons for not participating in the study were the expectation that filling out the questionnaires was too confronting (two couples) and unknown reason (eight couples). Table 1 shows caregivers' and patients' demographic characteristics, patients' treatment-related characteristics and caregivingrelated characteristics. The median age of caregivers' was 60 years; 66% were female and 78% were the patient's' spouse. The median age of patients was 66 years, and 43% were female. The mean duration of patients' treatment with a TKI was 44 months (SD 34).
Caregivers' general health (RAND-36), comorbidities (SCQ), burden (SPPIC), distress (HADS), marital satisfaction (MMQ) and discrepancies between need for social support and perceived social support (SSL-D)
Overall, scores on the RAND-36 showed that caregivers' general health was not significantly different from values of normative comparatives, except for pain, which was significantly worse (p < .001). Details are shown in Table 2 . The number of comorbidities affecting caregivers ranged from 0 (29.5%) to 7 (1.6%), with most between 0 and 2 (84%); 70% had one or more comorbidit(y)(ies). An overview of the number of comorbidities is given in Table 1 . An overview of the nature and treatment of comorbidities, is shown in Table 3 .
The mean score for burden was 2.4 (SD 2.3; range 0-9). Seventy-four percent (n ¼ 45) reported low, 16% (n ¼ 10) moderate and 10% (n ¼ 6) high levels of burden. Of the caregivers who reported low levels of burden, 18% (n ¼ 11) experienced no burden at all. The mean level of distress was 8.1 (SD 5.7; range 0-42) and 23% of the caregivers experienced high levels of distress. Discrepancies in social support showed a mean score of 39.2 (SD 6.7; range 34-136). Mean score for marital satisfaction was 9.3 (SD 9.3; range 0-80).
Caregivers' burden was significantly correlated with their own distress (r 0.584, p < .01) and patients' distress (r 0.442, p < .01). Furthermore, caregivers' distress was significantly correlated with patients' distress (r 0.375, p < .01).
Patients' general health (RAND-36), comorbidities (SCQ), distress (HADS), marital satisfaction (MMQ) and discrepancies between need for social support and perceived social support (SSL-D)
Patients' general health was significantly different to normative comparatives for every dimension measured, except for mental health, which was comparable. Details are shown in Table 2 . The number of comorbidities affecting patients ranged from 0 (21.3%) to 6 (4.9%), with the most between 0 and 3 (85.2%); 78.7% had one or more comorbidit(y)(ies). Details are given in Table 1 . Overall, the mean level of patients' general distress was 9.6 (SD 6.8; range 0-42) and 34% of patients experienced high levels of distress. Discrepancies in social support showed a mean score of 38.7 (SD 6.2; range 34-136). For marital satisfaction patients reported a mean score of 9.3 (SD 10.0; range 0-80).
Exploring caregivers' highlevels of burden and distress
When the caregivers who experienced high burden (n ¼ 6, 10%) were compared to caregivers with low and moderate burden (n ¼ 55, 90%), the caregivers with high levels of burden experienced significantly more distress (p ¼ .003), lower mental health (p ¼ .033), less vitality (p ¼ .019) and lower general health (p ¼ .038). High levels of burden were found in non-spouses (p ¼ .017), caregivers of patients experiencing more treatment side-effects (p ¼ .016), those who spent more hours caring (p ¼ .046) and those who were caring for more than one person (p ¼ .038). All caregivers with high levels of burden, had one of more comorbidit(y)(ies). Details are shown in Table 4 .
When caregivers with high levels of distress (n ¼ 14, 23%) were compared to caregivers with low levels of distress (n ¼ 47, 77%), the caregivers with high levels of distress experienced significantly more burden (p ¼ .001), lower levels of social functioning (p ¼ .016), more role physical problems (p ¼ .007), more role emotional problems (p ¼ .043), lower levels of mental health (p < .001), less vitality (p < .001), lower levels of general health (p ¼ .006). Furthermore, high levels of distress were found in caregivers of patients who were perceived as less independent (p ¼ .008) and in caregivers caring for more than one person (p ¼ .025). For caregivers with high levels of distress 79% had one or more comorbidit(y)(ies), but there was no difference in whether the caregiver had comorbidities (yes/no) between groups with low versus higher levels of distress. Details are shown in Table 5 .
The duration of treatment and setting in which the treatment was given (adjuvant or for metastatic GIST) did not differ between caregivers with high or low/moderate levels of burden, nor high and low levels of distress.
Discussion
The goal of this study was to explore caregivers' burden and distress during the patients' long-term treatment with TKI for GIST. Overall, caregivers of patients treated for GIST seem to manage well, as their levels of perceived burden and distress are low, their perceived general health is good and similar to the healthy population, their marital satisfaction seems good and they do not seem to experience discrepancies in social support. Fortunately, 90% of caregivers in this study perceived low to moderate levels of burden, of whom 18% did not perceive any burden at all. The burden of caregivers of the patients with cancer differ, but hardly any studies are performed in caregivers of patients treated with long-term TKIs. In a study by Haj Mohammed et al., where caregivers of oesophageal cancer patients were studied for burden 1 (2) 0 (0) ICR: interquartel range; ISCED: International Standard Classification of Education; SD: standard deviation. a One missing; b two missing; c more than one option possible. approximately 3 years after being treated with curative intent with neo-adjuvant chemoradiotherapy followed by resection, the percentage of low and moderate burden was 81% [24] . In a study by Hsu et al., exploring caregivers' burden of patients treated for cancer in early stage of disease (30%) or advanced disease (70%) for haematological and solid malignancies, low and moderate burden was found in 75% of caregivers [25] . Additionally, the multivariate analyses in the study by Hsu et al. showed that caregivers who were employed and providing support for activities of daily living, were at greater risk of high levels of burden [25] . According to the caregivers in our study, 84% of the caregivers spent less than 8 h weekly providing care to the patient and 92% of GIST patients: function independently of their caregivers in daily life, although the questionnaire did not define exactly what is meant by functioning independently. This may explain why the levels of burden in caregivers is perceived as low. Another reason may be that caregivers in our study experience low levels of discrepancies between their need for social support and their perceived social support. It Table 3 . Caregivers' comorbidities, treatment and perceived limitations in daily life.
Comorbidity
Total, n (%) Treatment, n (% of total) Impairments in daily functioning, n (% of total) Heart disease 7 (12) 7 (100) 4 (57) Stroke 0 (0) 0 (0) 0 (0) Hypertension 12 (20) 10 (83) 0 (0) Astma, chronic bronchitis, COPD 4 (7) 2 (33) 1 (25) Diabetes 1 (2) 1 (100) 0 (0) Ulcus stomach 0 (0) 0 (0) 0 (0) Kidney disease 0 (0) 0 (0) 0 (0) Liver disease 0 (0) 0 (0) 0 (0) Anaemia or other blood diseases 0 (0) 0 (0) 0 (0) Cancer 2 is known that social support is vital in preventing high levels of burden [10] . Furthermore, it is known that good copings skills may protect caregivers from overstretching themselves [10] . As the average duration of treatment of the patients in our sample was 44 months, this may have given caregivers time to adjust to patients' disease and treatment. On the other hand, our study showed that there was no difference between the groups of low/moderate and high levels of burden and low and high levels of distress according to the duration of treatment. This may also suggest that there is a group of caregivers that is not able to adjust over time.
Overall, we found that levels of distress were low. Distress in caregivers of patients on active treatment can arise due to worries about the efficacy of treatment, management of side-effects, social isolation, lack of experience when caring for a significant other and complexity of care [13] . Considering these risk factors, caregivers in our study experienced low levels of unmet needs for social support and the majority of the caregivers spent a low number of hours of providing care, which might protect them from distress. On the other hand, 50% of the patients in this study reported bothersome or severe side-effects of treatment and 34% of the patients experienced high levels of distress. The latter was associated with caregivers' levels of distress and burden. This, together with the need for continuous treatment, anxiety about computed tomography (CT) scans and results, may have contributed to high levels of distress in 23% of caregivers.
It is vital that attention is given to caregivers with high levels of distress and burden, as active treatment for patients with GIST is at least three years in the adjuvant setting and may be much longer with metastatic GIST. We identified a group of caregivers with high levels of burden (10%) or distress (23%), and compared them to the group of caregivers with low/moderate levels of burden or low levels of distress. Caregivers with high levels of burden, had significantly lower levels of mental health (i.e., feelings of sadness and anxiety), vitality (i.e., tiredness and lower levels of energy) and general health (i.e., perception of lower quality of personal general health). It is known that high levels of burden are associated with depressive symptoms, or even depression as an outcome, and our findings are therefore consistent with other studies [10, 13] . Regarding their general health, 100% of the caregivers with high levels of burden had one or more comorbidities, which is higher than the average for the Dutch population (between 42 and 52% above 55 years) [26] . Nevertheless, there was no significant difference in the number of comorbidities between the group with low/moderate and high levels of burden. This may be explained by the fact that most of the comorbidities reported by caregivers did not cause limitations in daily functioning, except for arthrosis, back pain and rheumatoid arthritis. The latter may explain why caregivers, overall, had significantly higher pain scores on RAND-36 compared with their normative comparatives. Nevertheless, only 2% reported they experienced a decline in their health as a consequence of caring for their significant other. Caregivers who perceived high levels of burden spent significantly more hours caring for their significant other and were more likely to care for more people other than the GIST patient alone. Adelman et al. described in their review that spending more hours caring is a risk factor for burden and Northouse et al. described that it is associated with disruption to their own lifestyle and interference with their own social activities causing social isolation [10, 11] . The latter may on its own contribute to distress, as we found that caregivers with high levels of distress had significantly more problems with social functioning. It may be that what normally protects caregivers against overstraining, such as moving on with their own life, their employment and social interaction, is insufficient and may lead to (serious) health problems, as found in other studies [10, 13, 27] . Furthermore, caregivers experiencing high levels of burden were shown to care for patients who had significantly more treatment-related sideeffects. An important TKI-related side-effect is severe fatigue, which was studied by Poort et al. This study showed that 30% of patients treated with a TKI for GIST were severely fatigued and this influenced their quality of life and impaired their overall functioning [28] . Pitceathly et al. described that caregivers' distress increases when a patient has more physical complaints [27] . It is conceivable that side-effects may influence many aspects of a patient's life and therefore also interfere with the well-being of caregivers, as they cope with the disease and its treatment as a couple [7, 8] .
This study had a number of limitations. Firstly, as far as we know, there are no validated cut-off points for measuring burden and distress in caregivers with the SPPIC and HADS, respectively. The SPPIC is a validated instrument to measure burden and is often used in clinical settings to measure cancer caregivers' burden. However, no reference data are available and there are no studies performed establishing validated cut-off scores. Nevertheless, for clinical practice, mean scores are often more difficult to interpret and during consultation it is useful to evaluate whether a caregiver experiences moderate or high levels of burden, in order to prioritise the need for support. Therefore, we decided to dichotomise with low and moderate versus high levels of burden, as with the study performed by Haj Mohammed et al. [24] Using this, we tried to identify the most vulnerable group of caregivers and explore risk factors for high levels of burden. Future studies could also focus on the group with moderate levels of burden or decide to combine moderate and high levels of burden, since moderate levels of burden could be of importance for caregivers of patients on longterm treatment. The HADS is also a validated questionnaire and often used to screen for distress among caregivers in clinical practice in the Netherlands. As for burden, to evaluate whether a caregiver experiences distress, a cut-off score could be helpful, however, there are no established cut-off scores to measure higher levels of caregivers' distress. Therefore, we adopted a cut-off score of 12, which is often used when screening for distress in general practice, and seems to have a satisfactory sensitivity for the total HADS scale, important for preventing too many false negatives [16] . We acknowledge that the HADS is especially useful as a first screening for distress and we want to emphasize that it is important to explore the cause of distress further when finding cases using cut-off scores.
In order to explore differences between low/moderate and high levels of burden and low and high levels of distress, we used multiple separate tests. With these tests we can only explore whether there were differences between the groups, without drawing conclusions about its cause or associations between variables. To determine association between the variables and possible causes of burden and distress, a multiple regression analysis would be of added value. Due to our small sample size we did not perform multiple regression analyses. The generalizability of this study may also be limited due to the small sample size. Future studies could perform these analyses with a larger sample size in order to prevent type II error. These studies could focus on this association to better understand burden and distress in this group of caregivers, using multiple regression analyses. This was a cross-sectional study and therefore, we cannot draw firm conclusions about causality. We also included both patients receiving curative, i.e., adjuvant, and palliative treatment, however this did not translate in differences in perceived burden and distress. We only studied a group of patients who were on TKI treatment for at least six months and had a prognosis of >12 weeks. Therefore, our results cannot be generalised to caregivers of patients at the start of TKI treatment or caregivers of GIST patients in the terminal phase of their lives. Our sample also did not include caregivers who were under the age of 18 years and were not able to communicate in the Dutch language. These caregivers could be another interesting group of caregivers and it would be interesting to study them in the future. Lastly, there were two couples who did not want to participate as they felt that the questionnaires were too confronting. It is conceivable that these patients and/or caregiver may suffer from burden and/or distress. It is therefore possible that the levels of distress and burden might be even higher than observed in this study. In conclusion, caregivers of patients on long-term treatment for GIST with TKIs appear to manage well. Nevertheless, it is important to recognise caregivers who have high levels of burden and distress, associated with physical and mental health-related problems. Interestingly, the stage of disease for which the patient was treated, and the duration of the treatment, did not seem to impact the burden and distress, however treatment-related side-effects and more hours of caring were related. Healthcare professionals currently aim to involve caregivers in patient care through providing adequate information on how to deal with patients' treatment. Awareness of caregivers' health problems should be improved. Recognizing the burden and distress is an important initial step, however management may be challenging. Future research could focus on how to implement screening for caregivers' burden and distress, how to identify caregivers at high risk for burden and distress, and how to work with other professionals, including general practitioners, in caring for the caregiver.
